antineoplastisch middel
Enzyme inhibitor protein
Human epidermal growth factor receptor 2 inhibitor
immunosuppressivum
Monoclonal antibody
|
|
|
|
|
trastuzumab-emtansine (substantie)
trastuzumab-emtansine
Trastuzumab emtansine
Id
702836004
Status
Primitive
Has disposition
Human epidermal growth factor receptor 2 inhibitor
Has disposition
immunomodulator
Is modification of
trastuzumab